Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction

Eur J Heart Fail. 2000 Sep;2(3):325-32. doi: 10.1016/s1388-9842(00)00098-2.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Carbazoles / therapeutic use*
  • Carvedilol
  • Double-Blind Method
  • Humans
  • Incidence
  • Myocardial Infarction / complications
  • Myocardial Infarction / mortality*
  • Practice Guidelines as Topic
  • Propanolamines / therapeutic use*
  • Randomized Controlled Trials as Topic / methods*
  • Research Design
  • Safety
  • Survival Rate
  • United Kingdom / epidemiology
  • Ventricular Dysfunction, Left / drug therapy
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Left / mortality*

Substances

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Propanolamines
  • Carvedilol